1. Increased levels of anti-Encephalitozoon intestinalis antibodies in patients with colorectal cancer.
- Author
-
Nourrisson, Céline, Moniot, Maxime, Vercruysse, Leslie, Bonnin, Virginie, Pereira, Bruno, Barnich, Nicolas, Bonnet, Mathilde, Jary, Marine, Pezet, Denis, Gagnière, Johan, and Poirier, Philippe
- Subjects
RECOMBINANT proteins ,COLORECTAL cancer ,PROGNOSIS ,MICROSPORIDIA ,MICROSPORIDIOSIS - Abstract
Background: The prevalence of microsporidiosis in the general population, or within specific groups of individuals/patients, is largely underestimated. The absence of specific seroprevalence tools limits knowledge of the epidemiology of these opportunistic pathogens, although known since the 1980s. Since microsporidia hijack the machinery of its host cell and certain species multiply within intestinal cells, a potential link between the parasite and colorectal cancer (CRC) has been suggested. Methodology/principal findings: To explore a potential epidemiological link between microsporidia and CRC, we evaluated the seroprevalence of Encephalitozoon intestinalis among CRC patients and healthy subjects using ELISA assays based on two recombinant proteins, namely rEiPTP1 and rEiSWP1, targeting polar tube and spore wall proteins. ELISA were performed in 141 CRC patients and 135 healthy controls. Patients with CRC had significantly higher anti-rEiPTP1 IgG levels than subjects in the control group. Anti-rEiPTP1 IgG, anti-rEiSWP1 IgG and anti-rEiPTP1 IgA levels were significantly increased among men with CRC compared to healthy men. Women with CRC who had died had higher rEiSWP1 IgG levels than those who were still alive. Conclusions/Significance: These higher antibody levels against microsporidia in patients with CRC suggest a relationship between microsporidia and pathophysiology of CRC. Author summary: The role of infectious agents in the occurrence of cancer is increasingly studied. Microsporidia are pathogens that can cause intestinal damage leading to severe diarrhea in humans. Data previously published would allow to consider a role of microsporidia in the occurrence of colorectal cancer. Our objective here was to provide epidemiological data concerning the association of microsporidia and cancer, which will be additional arguments that can justify in-depth work to study a potential causal link. To do this, we have developed tests to detect antibodies directed against a species of microsporidia, Encephalitozoon intestinalis. Our results show higher levels of antibodies against E. intestinalis among patients with colorectal cancer, compared to individuals without cancer, particularly in men. We also found that levels of certain antibodies were lower in women who survived cancer compared to those who died, possibly suggesting that this is a prognostic marker. All of these results support an epidemiological link between microsporidia, or at least certain species, and colon carcinogenesis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF